Clinical Trials Logo

Filter by:
NCT ID: NCT02637544 Recruiting - Clinical trials for Temporomandibular Disorders

Treatment Efficiency of Acupuncture in Non Chronified Pain Patients With TMDs

Start date: April 2014
Phase: N/A
Study type: Interventional

Aim of this randomized clinical trial is to examine the treatment effectiveness of an acupuncture protocol in adult patients with non chronified TMDs.

NCT ID: NCT02637011 Recruiting - Clinical trials for Acute Respiratory Distress Syndrome (ARDS)

Surviving ARDS: The Influence of Quality of Care and Individual Patient Characteristics on Quality of Life

DACAPO
Start date: September 2014
Phase: N/A
Study type: Observational

The purpose of the DACAPO study ("Surviving ARDS: the influence of quality of care and individual patient characteristics on quality of life") is to investigate the role of quality of care and individual patient characteristics on quality of life and return to work in survivors of ARDS (acute respiratory distress syndrome). It is hypothesized that higher quality of care is associated with better health-related quality of life and a higher rate of return to work among survivors. A prospective, observational, multi-centre patient cohort study is performed in Germany, using hospitals from the "ARDS Network Germany" as the main recruiting centres. It is envisaged to recruit 2400 patients into the DACAPO study and to analyze a study population of 1500 survivors. They will be followed up until 12 months after discharge from hospital. Quality of care will be assessed as process quality, structural quality and volume at the institutional level. The main outcomes (health related quality of life and return to work) will be gathered by self-report questionnaires. Further data assessment includes general medical and ARDS-related characteristics of patients as well as sociodemographic and psycho-social parameters. Multilevel hierarchical modelling will be performed to analyse the effects of quality of care and individual patient characteristics on outcomes, taking the cluster structure of the data into account.

NCT ID: NCT02635373 Recruiting - Calciphylaxis Clinical Trials

European Calciphylaxis Registry Network

EuCalNet
Start date: December 2015
Phase: N/A
Study type: Observational [Patient Registry]

Observational, registry, prospective, non-interventional collection of CUA patient data. Patient treatment is carried out within clinical routine, at the discretion of the physicians and according to existing treatment guidelines. Participating physicians will not be subject to any instructions with regard to the diagnosis and therapy of their patients.

NCT ID: NCT02631798 Recruiting - Chromoendoscopy Clinical Trials

Chromocolonoscopy With Food-grade Dyes

Start date: December 2015
Phase: N/A
Study type: Interventional

Previous with methylene blue suggested that oral administration may be superior to conventional spray catheters. The main advantages claimed were better staining due to longer exposure to the dye, more uniform staining due to normal position of the intestines (during conventional chromocolonoscopy, patients are lying on one side), and a quicker and more comfortable procedure for the patients and endoscopy personnel. Using food-grade dyes would enable higher dye loads and lower systemic side effects. Food grade dyes will be administered orally during preparation with KleanPrep (total amount of 4 liters) in patients undergoing screening colonoscopy. On day 1 patients will drink 3 l of the preparation solution, the last liter together with the last dose of dye will be administered 5 hours before scheduled colonoscopy. Primary endpoints: - quality of mucosal staining of colon (assessed by questionnaire) Secondary endpoints: - adenoma detection rate - adverse events - time of colonoscopy

NCT ID: NCT02628067 Recruiting - Cervical Cancer Clinical Trials

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)

Start date: December 18, 2015
Phase: Phase 2
Study type: Interventional

In this study, participants with multiple types of advanced (unresectable and/or metastatic) solid tumors who have progressed on standard of care therapy will be treated with pembrolizumab (MK-3475).

NCT ID: NCT02628015 Recruiting - Premature Birth Clinical Trials

Theory of Mind in Preschool Children, School Children, Youths and Adults Born Preterm or Full-term

Start date: March 2016
Phase: N/A
Study type: Observational

This study tests preschoolers, school children, youths and young adults, who were born preterm or full-term, in their theory of mind abilities.

NCT ID: NCT02627833 Recruiting - Clinical trials for Bronchiolitis Obliterans

Lung Function, LCI, Bronchial Inflammation and Epigenetics of Patients With BO

FRABO-03
Start date: October 2015
Phase: N/A
Study type: Observational

Bronchiolitis obliterans is a chronic disease in which a persistent inflammatory process leads to obliteration of the small airways. Pulmonary function tests (body plethysmography with DLCO, lung clearance index) are performed and the fraction of exhaled nitric oxide is measured. A blood test is following to determine the inflammatory status und collect miRNA. Induced Sputum will be obtained.

NCT ID: NCT02627781 Recruiting - Clinical trials for Reduction of Negative Appendectomy Rate

Diagnostic Algorithm for Appendizitis (DIALAPP)

DIALAPP
Start date: November 2015
Phase: N/A
Study type: Observational [Patient Registry]

The diagnosis of acute appendicitis remains a challenge in daily clinical practice. The high incidence of appendicitis drives the need to reduce morbidity and unnecessary costs due to negative appendectomies. The aim of the present observation study is to evaluate a diagnostic and therapeutic algorithm for suspected acute appendicitis. The investigators believe that this diagnostic algorithm helps to simultaneously avoid unnecessary operations, costs and radiation exposure.

NCT ID: NCT02622581 Recruiting - Clinical trials for Small-cell Lung Cancer

Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients

CRISP
Start date: December 2015
Phase:
Study type: Observational [Patient Registry]

Open, non-interventional, prospective, multi-center clinical research platform with the main objective to assess molecular biomarker testing, treatment and outcome of patients with NSCLC or SCLC in Germany

NCT ID: NCT02621645 Recruiting - Clinical trials for Twin Reversal Arterial Perfusion Syndrome

TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

TRAPIST
Start date: May 2016
Phase: Phase 4
Study type: Interventional

Multi-center open-label randomized controlled trial to assess if early intervention (12.0-14.0 weeks) (study group) improves the outcome of TRAP sequence as compared to late intervention (16.0-19.0 weeks) (control group). The investigators will randomly assign women diagnosed with TRAP sequence diagnosed between 12.0 and 13.6 weeks to an early or late intervention group (1:1), using a web-based application and a computer-generated list with random permuted blocks of sizes 2 or 4 (www.sealedenvelope.com), stratified by gestational age (GA) at inclusion (11.6 -12.6 weeks versus 13.0-13.6 weeks). Analysis will be by intention to treat.